Looking forward to supporting #patients with #cancer now that this pan-EU RCT has shown the effectiveness of DOC@HOME in #symptommanagement Read more here: https://t.co/1eDqfzTERY #BMJresearch
RT @DocoboUK: Read more about #remotemonitoring during chemotherapy for cancer #digitalhealth
RT @DocoboUK: Read more about #remotemonitoring during chemotherapy for cancer #digitalhealth https://t.co/dIEFQAbhE7
RT @DocoboUK: Read more about #remotemonitoring during chemotherapy for cancer #digitalhealth https://t.co/dIEFQAbhE7
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) #lymphoma #lymsm https://t.co/JdGdligcsg
RT @NDodlek: Congrads @nursGK704 &colleagues on amasing work!! @cancernurseEU https://t.co/q7mwkGcPWM
Loving these primary outcomes👇🏻 ‘Symptom burden, quality of life, supportive care needs, anxiety, self-efficacy, and work limitations’ Real time remote symptom monitoring during chemotherapy for cancer: European multicentre RCT (eSMART) | The BMJ https:
Loving these primary outcomes👇🏻 ‘Symptom burden, quality of life, supportive care needs, anxiety, self-efficacy, and work limitations’ Real time remote symptom monitoring during chemotherapy for cancer: European multicentre RCT (eSMART) | The BMJ https:/
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
Read more about #remotemonitoring during chemotherapy for cancer #digitalhealth
Congrads @nursGK704 &colleagues on amasing work!! @cancernurseEU https://t.co/q7mwkGcPWM
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
👇🏼 Results from an RCT, conducted at multiple centres across Europe, showing the benefits of remote patient monitoring and highlighting the vital role it will play in services going forward - congratulations @roma_maguire @Lisa_McCann_ and colleagues
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @GlasgowlovesEu: Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this…
Great to see @roma_maguire @UniStrathclyde leading an innovative research project funded by @EU_Commission Will this be one of the last #EU funded project to be lead by #Glasgow based academics? Are we to become a scientific backwater? @mikegalsworthy h
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/BSyHdIxTVY
You can read the full article here https://t.co/LJYQU6yHZa
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/gE3SK8Uc4A
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @CancerAtSurrey: Findings from the eSMART study are out! Showing how remote symptom monitoring during #chemotherapy improves #cancer pat…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) #lymphoma #lymsm https://t.co/3u3qi3JWWx
New article: Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART) https://t.co/pmOv0c8AKL #colorectalcancer #oncology https://t.co/f3U2cWamZy
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @Lisa_McCann_: Delighted to be able to share the main results of the eSMART study via this @bmj_latest publication. Thank you to all the…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage side effects and improve quality of life, finds a study published by @bmj_latest today https://t.co/2bMaUi38vR @roma_maguire
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @Lisa_McCann_: Delighted to be able to share the main results of the eSMART study via this @bmj_latest publication. Thank you to all the…
RT @Lisa_McCann_: Delighted to be able to share the main results of the eSMART study via this @bmj_latest publication. Thank you to all the…
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
RT @Lisa_McCann_: Delighted to be able to share the main results of the eSMART study via this @bmj_latest publication. Thank you to all the…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @Lisa_McCann_: Delighted to be able to share the main results of the eSMART study via this @bmj_latest publication. Thank you to all the…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
Delighted to be able to share the main results of the eSMART study via this @bmj_latest publication. Thank you to all the patients, clinicians and collaborators who worked with us during the study #remotemonitoring #digitalhealth
RT @roma_maguire: Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership wo…
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
Main results of the eSMART trial in the BMJ today. Was a privilege to work with such a great consortium - partnership working at its best!
Our new paper out @esmart_eu! PROM-based remote symptom monitoring is linked to statistically significant and clinically important gains in patient reported outcomes during chemotherapy. #Cancer #supponc #proms
RT @adarleyresearch: The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the suppor…
The eSMART results are out today showing how people with cancer can self-manage their symptoms at home with the support of mobile technology. Fantastic experience working with participants, clinicians and European partners! @FurlongEileen @UCD_Research @
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Our eSMART study showed remote monitoring improves cancer patient outcomes. So proud to have worked with this amazing team @esmart_eu @CancerAtSurrey @UniOfSurrey
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
RT @bmj_latest: Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJr…
Remote 24-hour monitoring for cancer patients receiving chemotherapy helps to better manage symptom burden, finds new #BMJresearch https://t.co/BcLN2iBGx6 @roma_maguire